Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages

Qianqian Zhang, Sijin Cheng, Yongzhi Wang, Mengdi Wang, Yufeng Lu, Zengqi Wen, Yuxin Ge, Qiang Ma, Youqiao Chen, Yaowu Zhang, Ren Cao, Min Li, Weihao Liu, Bo Wang, Qian Wu, Wenqing Jia, Xiaoqun WangNature Communications 2021 · DOI

Abstract

Spinal ependymomas are the most common spinal cord tumors in adults, but their intratumoral cellular heterogeneity has been less studied, and how spinal microglia are involved in tumor progression is still unknown. Here, our single-cell RNA-sequencing analyses of three spinal ependymoma subtypes dissect the microenvironmental landscape of spinal ependymomas and reveal tumor-associated macrophage (TAM) subsets with distinct functional phenotypes. CCL2<sup>+</sup> TAMs are related to the immune response and exhibit a high capacity for apoptosis, while CD44<sup>+</sup> TAMs are associated with tumor angiogenesis. By combining these results with those of single-cell ATAC-sequencing data analysis, we reveal that TEAD1 and EGR3 play roles in regulating the functional diversity of TAMs. We further identify diverse characteristics of both malignant cells and TAMs that might underlie the different malignant degrees of each subtype. Finally, assessment of cell-cell interactions reveal that stromal cells act as extracellular factors that mediate TAM diversity. Overall, our results reveal dual functions of TAMs in tumor progression, providing valuable insights for TAM-targeting immunotherapy.

Introduction

Spinal ependymomas represent the most prevalent primary spinal cord tumors in the adult population. Despite surgery being the primary therapeutic intervention, the invasive growth patterns of these tumors often preclude complete resection, leading to high rates of recurrence. A significant barrier to developing more effective treatments has been a lack of understanding regarding the tumor microenvironment (TME)—the intricate network of immune cells, vasculature, and structural components that support tumor growth. In particular, the role of resident microglia and infiltrating macrophages in spinal tumor progression has remained poorly defined. This study aims to map these interactions at single-cell resolution to identify novel therapeutic vulnerabilities.

Methods and Data Integration

To achieve a high-resolution map of the spinal ependymoma TME, researchers utilized a multi-omic approach. The study integrated single-cell RNA sequencing (scRNA-seq) of approximately 150,000 cells from 15 treatment-naive patients, covering three clinical subtypes: Subependymoma (SE), Ependymoma (EPN), and Anaplastic Ependymoma (AEP).

Experimental workflow for single-cell profiling of spinal ependymomas, illustrating the process from patient resection to expression profiling.

The analysis was supplemented by single-cell ATAC-seq to identify regulatory transcription factors and bulk ChIP-seq for epigenetic context. Computational tools such as Harmony were used for data integration, while CellPhoneDB and NicheNet were employed to model intercellular communication. Lineage tracing was performed using RNA velocity to determine the developmental origins of immune cell populations.

Key Insights: The Dual Nature of TAMs

The study's most significant finding is the functional divergence of tumor-associated macrophages (TAMs), moving beyond the simplistic M1/M2 classification. Two distinct subsets were identified:

  1. $CCL2^+$ TAMs: These cells are primarily derived from resident microglia, are linked to immune activation, and show a high propensity for apoptosis, suggesting an anti-tumor role.
  2. $CD44^+$ TAMs: These cells, derived from both microglia and blood monocytes, are pro-angiogenic. They facilitate the formation of new blood vessels, thereby supporting tumor progression.
UMAP visualization of 125,833 malignant cells, demonstrating the significant inter-patient and inter-subtype heterogeneity.

The researchers identified TEAD1 and EGR3 as the master transcription factors regulating these pro-tumor and anti-tumor states, respectively. Furthermore, stromal cells (fibroblasts and pericytes) were found to act as "trainers," secreting factors like CTGF and PGF that recruit and program macrophages toward these specific functional phenotypes.

Clinical Implications and Results

The study demonstrated that a high $CD44^+$ TAM signature correlates with significantly worse survival outcomes in glioma patients, marking it as a potential prognostic biomarker. Aggressive subtypes, such as AEP, exhibited a higher proportion of these specialized TAM subsets compared to benign SE tumors. Additionally, the identification of the NFIB-CDH6 regulatory program highlights a mechanism for Epithelial-Mesenchymal Transition (EMT), which drives malignancy and invasiveness. By cross-referencing these findings with drug databases, the authors identified numerous druggable targets specific to malignant cell clusters.

Limitations and Future Directions

While the scRNA-seq data is extensive, the scATAC-seq analysis was limited to a small number of AEP patients, potentially missing regulatory nuances in other subtypes. The study is primarily observational; therefore, the functional roles of identified regulators like TEAD1 and EGR3 require validation in functional assays or animal models. Future work will also need to address the complexities of lineage tracing in the human TME to definitively confirm the origins of these macrophage subsets.

In conclusion, this research provides a comprehensive atlas of the spinal ependymoma microenvironment, suggesting that "reprogramming" the TME—specifically by targeting pro-tumor TAMs or their stromal signals—could offer a potent new strategy for immunotherapy.

Summary updated

Abstract

Spinal ependymomas are the most common spinal cord tumors in adults, but their intratumoral cellular heterogeneity has been less studied, and how spinal microglia are involved in tumor progression is still unknown. Here, our single-cell RNA-sequencing analyses of three spinal ependymoma subtypes dissect the microenvironmental landscape of spinal ependymomas and reveal tumor-associated macrophage (TAM) subsets with distinct functional phenotypes. CCL2<sup>+</sup> TAMs are related to the immune response and exhibit a high capacity for apoptosis, while CD44<sup>+</sup> TAMs are associated with tumor angiogenesis. By combining these results with those of single-cell ATAC-sequencing data analysis, we reveal that TEAD1 and EGR3 play roles in regulating the functional diversity of TAMs. We further identify diverse characteristics of both malignant cells and TAMs that might underlie the different malignant degrees of each subtype. Finally, assessment of cell-cell interactions reveal that stromal cells act as extracellular factors that mediate TAM diversity. Overall, our results reveal dual functions of TAMs in tumor progression, providing valuable insights for TAM-targeting immunotherapy.
BibTeX
@inproceedings{zhang2021interrogation,
  author = {Qianqian Zhang and Sijin Cheng and Yongzhi Wang and Mengdi Wang and Yufeng Lu and Zengqi Wen and Yuxin Ge and Qiang Ma and Youqiao Chen and Yaowu Zhang and Ren Cao and Min Li and Weihao Liu and Bo Wang and Qian Wu and Wenqing Jia and Xiaoqun Wang},
  title = {{Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages}},
  booktitle = {Nature Communications},
  year = {2021},
  doi = {10.1038/s41467-021-27018-9},
}
Figure